La maladie de Parkinson en France (serveur d'exploration) - Merge (PascalFrancis)

Index « FA11s1.i » - entrée « OLANOW (C. Warren) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
OLANOW (C. W.) < OLANOW (C. Warren) < OLANOW (Warren)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000175 (2000) C. Warren Olanow ; Anthony H. V. Schapira ; Olivier RascolContinuous dopamine-receptor stimulation in early Parkinson's disease
000679 (2004) C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio StocchiLevodopa in the treatment of Parkinson's disease: Current controversies
000959 (2007) Christopher G. Goetz ; Stanley Fahn ; Pablo Martinez-Martin ; Werner Poewe ; Cristina Sampaio ; Glenn T. Stebbins ; Matthew B. Stern ; Barbara C. Tilley ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic ; Jaime Kulisevsky ; Anthony E. Lang ; Andrew Lees ; Sue Leurgans ; Peter A. Lewitt ; David Nyenhuis ; C. Warren Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne A. Teresi ; Jacobus J. Van Hilten ; Nancy LapelleMovement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) : Process, format, and clinimetric testing plan
000961 (2007) Christopher G. Goetz ; Philippe Damier ; Christine Hicking ; Eugene Laska ; Thomas Müller ; C. Warren Olanow ; Olivier Rascol ; Hermann RussSarizotan as a treatment for dyskinesias in Parkinson's disease : A double-blind placebo-controlled trial
000B10 (2008) Christopher G. Goetz ; Eugene Laska ; Christine Hicking ; Philippe Damier ; Thomas Müller ; John Nutt ; C. Warren Olanow ; Olivier Rascol ; Hermann RussPlacebo Influences on Dyskinesia in Parkinson's Disease
000B89 (2008) C. Warren Olanow ; Robert A. Hauser ; Joseph Jankovic ; William Langston ; Anthony Lang ; Wemer Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier RascolA Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics
000B91 (2008) Christopher G. Goetz ; Barbara C. Tilley ; Stephanie R. Shaftman ; Glenn T. Stebbins ; Stanley Fahn ; Pablo Martinez-Martin ; Wemer Poewe ; Cristina Sampaio ; Matthew B. Stem ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic ; Jaime Kulisevsky ; Anthony E. Lane ; Andrew Lees ; Sue Leurgans ; Peter A. Le Witt ; David Nyenhuis ; C. Warren Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne A. Teresi ; Jacobus J. Van Hilten ; Nancy LapelleMovement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results
000D00 (2009) C. Warren Olanow ; Olivier Rascol ; Robert Hauser ; Paul D. Feigin ; Joseph Jankovic ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo TolosaA Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
000D78 (2010) C. Warren Olanow ; O. RascolThe delayed-start study in Parkinson disease: Can't satisfy everyone
001031 (2012) Andrew Lees ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic ; Anthony Lang ; Federico Micheli ; M. Maral Mouradian ; Wolfgang H. Oertel ; C. Warren Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh KumarPerampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease
001260 (2014) Anthony H. V. Schapira ; C. Warren Olanow ; J. Timothy Greenamyre ; Erwan BezardMovement disorders 3: Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "OLANOW (C. Warren)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i  \
                -Sk "OLANOW (C. Warren)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Merge
   |type=    indexItem
   |index=    FA11s1.i
   |clé=    OLANOW (C. Warren)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024